Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
Shares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the
Read MoreShares of other biotech companies developing ADCs, which are among the hottest areas in the pharmaceutical industry, jumped on the
Read MoreThe investment bank's chief U.S. equity strategist says the risk of recession will be higher than normal next year —
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreJudge Michael Newman of the Southern District of Ohio issued a ruling denying a preliminary injunction sought by the Chamber of
Read MoreThe Gilman Hill Asset Management CEO revealed to CNBC's "Art of the Trade" that her best trade ever is all
Read MoreIt's still unclear which drugs Medicare will select, but several companies have revealed in court filings that four of their
Read MoreSenate Finance Committee Democrats said the Republican bill resulted in billion of dollars in tax savings for pharmaceutical companies. Source
Read MoreAs stocks sell off, investors are searching for some stability in fixed income — and that's lifting two bond ETFs.
Read MoreHere are the biggest calls on Wall Street on Source link
Read More